Everest Organics (EVERESTO) | Stock Overview & Key Data
Everest Organics Performance Comparison
Stock Range
Today's Range
Low: ₹404.25
High: ₹414.50
on August 25, 2025
52 Week Range
Low: ₹112.50
High: ₹477.00
on November 13, 2024
on May 8, 2025
All-Time High: ₹477.00 on May 5, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR4.0B
EPS
6.11
P/E Ratio (TTM)
67.51
Forward P/E
N/A
P/B Ratio
12.73
PEG Ratio
-0.57
Div. Yield
N/A
ROE
-1.84%
Beta
0.140
Debt to Equity
68.44
Financial Highlights
Profitability
Gross Margin
31.15%
Operating Margin
6.39%
Profit Margin
3.41%
Returns and Earnings
Return on Assets (TTM)
-0.57%
Return on Equity (TTM)
-1.84%
EBITDA
INR162.3M
Net Income (TTM)
INR62.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR187.18
Quarterly Revenue Growth (YoY)
65.90%
Quarterly Earnings Growth (YoY)
65.86%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Everest Organics EVERESTO | 4.01B Small-cap | 12.60% | 20.97% | -5.37% | 66.13% | 37.04% | 200.88% | 219.64% | 46.82% |
| Sun Pharmaceutical SUNPHARMA | 3.95T Large-cap | 0.56% | -2.16% | -4.47% | 0.14% | -13.13% | -7.54% | 86.54% | 195.42% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -0.21% | -6.98% | -5.91% | 7.87% | 1.29% | 26.68% | 71.47% | 87.96% |
| Sun Pharma Advanced SPARC | 47.41B Small-cap | 1.72% | -7.23% | -10.11% | 14.74% | -27.21% | -34.43% | -37.13% | -23.18% |
| Sequent Scientific SEQUENT | 44.38B Small-cap | 0.12% | -6.92% | -2.35% | 12.64% | -4.77% | 5.41% | 52.52% | 30.60% |
| Gujarat Themis GUJTHEM | 43.50B Small-cap | 10.88% | 7.56% | 26.97% | 64.54% | 64.54% | 83.00% | 83.00% | 83.00% |
Ownership & Short Interest
Insider Ownership
78.38%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
6K
Average 90-Day Volume
3K
Everest Organics Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Everest Organics would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is EVERESTO's 52-week high and low?
- In the last 52 weeks, Everest Organics reached a high of ₹477.00 (on May 8, 2025) and a low of ₹112.50 (on November 13, 2024).
- What is the market cap and P/E ratio for EVERESTO?
- Curious about Everest Organics's size and valuation? Its market capitalization stands at 4.01B. When it comes to valuation, the P/E ratio (trailing twelve months) is 67.51, and the forward P/E (looking ahead) is N/A.
- Does EVERESTO pay dividends? If so, what's the yield?
- As for dividends, Everest Organics isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Everest Organics's main competitors or similar companies to consider before investing?
When looking at Everest Organics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.95T Healthcare Drug Manufacturers - Specialty & Generic -7.54% 86.54% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 26.68% 71.47% Sun Pharma Advanced
SPARC47.41B Healthcare Drug Manufacturers - Specialty & Generic -34.43% -37.13% Sequent Scientific
SEQUENT44.38B Healthcare Drug Manufacturers - Specialty & Generic 5.41% 52.52% Gujarat Themis
GUJTHEM43.50B Healthcare Drug Manufacturers - Specialty & Generic 83.00% 83.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Everest Organics Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Everest Organics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -1.84%, the Debt to Equity ratio from the most recent quarter is 68.44, and its Gross Profit Margin stands at 31.15%.
- What is the recent revenue and earnings growth for EVERESTO?
- Looking at Everest Organics's growth, its revenue over the trailing twelve months (TTM) was INR2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 65.90%, and quarterly earnings saw a YoY growth of 65.86%.
- How much of EVERESTO stock is held by insiders and institutions?
- Wondering who owns Everest Organics stock? Company insiders (like executives and directors) hold about 78.38% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.